| Names | |
|---|---|
| Preferred IUPAC name | Cyclopentene |
| Other names | 1-Cyclopentene CYCLOPENTENE CPE |
| Pronunciation | /ˌsaɪ.kləˈpen.tiːn/ |
| Identifiers | |
| CAS Number | 142-29-0 |
| Beilstein Reference | 1720231 |
| ChEBI | CHEBI:18149 |
| ChEMBL | CHEMBL15360 |
| ChemSpider | 7496 |
| DrugBank | DB14096 |
| ECHA InfoCard | 03e218d7-da2f-4633-857e-c6b1e58312ea |
| EC Number | 203-657-9 |
| Gmelin Reference | 136379 |
| KEGG | C01877 |
| MeSH | D003545 |
| PubChem CID | 9253 |
| RTECS number | GV0700000 |
| UNII | R3T7GA7W9F |
| UN number | UN2242 |
| Properties | |
| Chemical formula | C5H8 |
| Molar mass | 68.12 g/mol |
| Appearance | Colorless liquid |
| Odor | mild aromatic |
| Density | 0.777 g/cm³ |
| Solubility in water | Insoluble |
| log P | 1.99 |
| Vapor pressure | 5.2 atm at 20 °C |
| Acidity (pKa) | 16.0 |
| Basicity (pKb) | 15.99 |
| Magnetic susceptibility (χ) | -19.6×10⁻⁶ |
| Refractive index (nD) | 1.423 |
| Viscosity | 0.39 mPa·s (20°C) |
| Dipole moment | 0.45 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 266.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -9.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3307.0 kJ/mol |
| Pharmacology | |
| ATC code | |
| Hazards | |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS02,GHS07 |
| Signal word | Warning |
| Precautionary statements | P210, P233, P240, P241, P242, P243, P261, P264, P271, P301+P310, P303+P361+P353, P304+P340, P305+P351+P338, P313, P337+P313, P370+P378, P403+P235, P405, P501 |
| NFPA 704 (fire diamond) | 2-4-2 |
| Flash point | −31 °C (−24 °F; 242 K) |
| Autoignition temperature | 385 °C |
| Explosive limits | 1.4–11.8% |
| Lethal dose or concentration | LD50 oral rat 2100 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50: 288 mg/kg |
| NIOSH | EPA P043 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5 ppm (1.5 mg/m³) |
| IDLH (Immediate danger) | 1500 ppm |
| Related compounds | |
| Related compounds | Cyclopentane 1,3-Cyclopentadiene Vinylcyclopentene Methylcyclopentene Cyclohexene Cyclobutene |
| Product Name | Cyclopentene |
|---|---|
| IUPAC Name | Cyclopentene |
| Chemical Formula | C5H8 |
| CAS Number | 142-29-0 |
| Synonyms & Trade Names | Cyclopentylene; UN 3296 |
| HS Code & Customs Classification | 2902.19 (Cyclic hydrocarbons, cyclopentene) |
Cyclopentene presents a straightforward identification profile, yet each field listed above can reflect significant downstream impacts based on the needs of application, quality control, and regulatory compliance.
Our documentation uses the IUPAC nomenclature Cyclopentene as it aligns with both international chemical regulatory submissions and internal quality assurance records. Consistency here streamlines coordination with regulatory bodies and third-party labs during compliance audits and import/export filings.
C5H8 defines cyclopentene’s molecular identity for quality control assays, such as GC-MS and elemental analysis. Monitoring the hydrocarbon skeleton is crucial during the manufacturing process, as hydroisomerization or overhydrogenation can divert production yield toward other C5 cyclics or saturates. Analytical method selection often tracks this ratio through in-process controls and final QC release.
Cyclopentene’s main synonym, cyclopentylene, may appear on batch paperwork and MSDS references, especially when dealing with international customers. Detailed tracking of trade names minimizes mislabeling risks at distribution terminals and avoids packaging errors, which also supports proper hazardous material documentation for logistics and export.
CAS 142-29-0 serves as a global unique identifier. Batch traceability, registration documents for new markets, and digital logistics systems rely on this code. Errors in the CAS number on regulatory filings can cause border clearance delays and additional analytical checks by customs authorities. All internal release certificates cross-reference the CAS number as part of our batch audit trail.
The application of 2902.19 for customs classification concerns not only export documentation but also tariff calculation and destination market chemical control. This code ties to cyclical hydrocarbon excise requirements in certain jurisdictions, and any ambiguity can trigger reclassification risks at customs. From a manufacturer’s perspective, assigning this code involves reviewing the product’s exact structural features and ensuring alignment with both WCO and local customs guidance.
In practice, chemical identification details often dictate batch documentation, plant labeling, QA cross-checks, and customs declaration rules. The specificity within each property area, down to grade-level detail, uses a combination of process analytical data, lab release findings, and regulatory documentation collated by the technical, quality, and regulatory groups. Deviations or ambiguities in identification can disrupt supply chain flows, impact regulatory status, or generate rework at the plant or regulatory interaction point.
Cyclopentene is normally handled as a clear, colorless liquid in most industrial settings. Odor is often described as sweet yet petrol-like, which is noticeable during sampling or transfer operations. Boiling point and melting point behavior shifts based on pressure; distillation environments require careful control due to the product's volatility. Flash point is a key consideration for plant handling, varying with impurities and grade.
Measured densities may shift depending on grade and temperature; technical-grade material produced from industrial syntheses often varies within a narrow range. Solubility is negligible in water but greater in organic solvents; solution preparation practices must avoid emulsification and unnecessary aeration to minimize peroxide formation risks.
Reactivity increases under UV light or in the presence of acids or peroxides. Storage tanks and transfer lines require inert gas blanketing, especially for higher-purity grades. Any trace oxygen, acidic residue, or metal can accelerate degradation—prompting regular system purging and internal surface checks.
Cyclopentene grades are defined by application—polymerization, pharmaceutical synthesis, or intermediate use. Each grade is matched to purity, moisture, and allowable by-product levels. Typical values depend on customer and downstream requirements; grades may be defined with respect to non-hydrocarbon residue, sulfur content, and water level.
| Property | Grade A (High Purity) | Grade B (Technical) |
|---|---|---|
| Purity (%) | Defined by customer spec | Application-dependent |
| Water (ppm) | Grade limit specified | In-process controlled |
| Impurities (total) | Release spec controlled | Batch-specific |
Major impurities in plant output arise from by-products of the synthesis route as well as feedstock-derived minor hydrocarbons. Control of dienes, peroxides, and unsaturated oligomers is crucial. The final release standard is subject to internal quality control criteria and customer requirements, especially for downstream polymerization use.
Analytical methods are chosen based on grade and customer expectation. Gas chromatography with flame ionization detection remains the primary tool for purity and organic impurity assessment. Karl Fischer titration quantifies water. Methods reflect international and internal standards, confirmed during batch release.
Feedstock selection is dictated by process design and raw material availability in the region. Naphtha and cyclopentane-rich streams are most often used. Impurity load in feedstock drives both process efficiency and purification effort downstream.
Most processes rely on the dehydrogenation of cyclopentane or cracking of naphtha fractions; catalyst and thermodynamic parameters are tightly controlled. Hydrogen management and gas-phase operation are routinely optimized against reactor fouling and catalyst life.
Critical points in production start at feedstock pre-treatment, catalyst bed management, and end at distillation train control. Each step can introduce or reduce product impurities. Distillation columns are adjusted for target cut, depending on grade. Inert gas blanketing prevents peroxide formation in the post-purification phase.
Batch-to-batch consistency is managed with real-time analytics and periodic cross-verification before delivery. Release criteria are shaped by both technical grade and customer-imposed requirements, rather than a single internal threshold.
Cyclopentene participates in addition and polymerization reactions. Alkylation, hydroformylation, and oxidation are all practiced at scale under appropriate controls.
Catalyst systems for oligomerization and polymerization require exclusion of water and oxygen, typical for moisture-sensitive catalysts. At the manufacturing level, temperature and pressure windows are process- and product-specific. Side reactions increase with contaminants or temperature excursions.
Chosen modification path depends on end-use; production of cyclopentanol, cyclopentanone, and specialty polymers all require careful feedstock quality. Residual unsaturation and trace contaminants in cyclopentene affect final product quality and plant yield in downstream conversion units.
Storage tanks and drums use nitrogen or argon blanket. Light exclusion is standard for sensitive applications, minimizing peroxide risks. Drum and tank configuration varies with commercial grade and batch size; residual oxygen accelerates aging even in high-purity stock.
Metals that catalyze peroxide formation, such as copper, are strictly avoided in all wetted parts. Steel and compatible liners are used to prevent contamination and corrosion. Solvent wash is necessary during maintenance to prevent buildup and cross-contamination.
Product shelf life is a function of storage conditions and grade. Degradation may appear as color change or onset of odor. Presence of peroxides at detection limit marks the end of recommended storage; strict rotation based on production date preserves product functionality, especially for sensitive conversion routes.
Hazard classification aligns with its flammable, irritant nature. Toxicity hinges on grade and exposure level; even trace contamination raises long-term handling concerns.
Liquid and vapor ignition risks rise with poor ventilation and static discharge. Eye and skin contact require rapid rinsing and medical observation. Mechanical ventilation and closed handling systems prevent inhalation exposure in plant environments.
Historical industrial experience demonstrates central nervous system and respiratory sensitization at sufficient vapor concentrations. Chronic exposure management supports barrier PPE and active gas monitoring during factory operations. Spills are managed by established protocols with continuous training to avoid escalation.
Permissible exposure limits are set by local regulation and employer hazard assessments. Plant safety committees refine procedures to operator tasks, grade, and local regulation. In-plant transfer procedures, ventilation design, and safe tank entry protocols collectively minimize risk, especially for high-throughput production lines and maintenance operations.
In continuous production of cyclopentene, raw material sourcing and plant route selection are key determinants of monthly output. Capacity depends on the allocation of cracking units and the prioritization of feedstock, since cyclopentene production usually competes with other C5 derivatives in the separation stage. Grade-specific orders impact availability: higher-purity requirements or custom impurity profiles often require dedicated campaigns, affecting turnaround and throughput. Lead times tighten during turnarounds and feedstock supply disruptions, especially for high-purity or low-odor applications. Export-oriented supply must comply with destination-specific regulatory documentation.
Lead times for standard industrial-grade CPE shipments typically align with plant’s campaign schedules and logistical windows. Orders requiring analytical documentation, custom purity blocks, or non-standard packaging usually extend lead time. Minimum order quantity for CPE varies by product grade and packing format, with lower MOQs on drums versus ISO tank shipment. For custom specification batches, MOQ will reflect both equipment utilization constraints and yield considerations from the distillation setup.
Packaging is determined by both product stability and downstream application. Common options depend on logistics: steel drums for regional supply, ISO tanks or flexi-bags for export, and specialized inert-lined containers for high-purity or polymer-grade CPE. Grade-specific packaging is selected following compatibility checks with both product and supply chain requirements, to mitigate contamination or evaporation risks.
Shipping methods reflect hazard classification, destination compliance, and customer storage capability. Routinely, shipments involve bulk logistics and require up-to-date safety and compliance documentation, especially in US/EU/JP where regulatory controls are regularly updated. Standard payment terms reflect contractual arrangements and credit risk policies. For larger or specialty orders, partial advance payment and letter of credit requirements are typical for international partners.
The primary cost drivers for cyclopentene stem from upstream naphtha or condensate cracking costs, C5 fraction availability, and the operational efficiency of extraction or catalytic dehydrogenation units. Feedstock selection logic varies regionally: naphtha cracking output fluctuates alongside fluctuations in light olefin demand. Grade-specific costs amplify with tighter impurity thresholds due to incremental purification steps, more rigorous analytical controls, and yield sacrifice during batch release.
Raw material prices shift according to energy cost volatility, changes in refinery operating rates, and disruptions in petrochemical feedstock allocation. Market tightness for key by-products such as isoprene and piperylene also influences the cyclopentene price pool. Short-term pricing volatility often arises from export controls, unplanned plant outages, and seasonal demand swings—particularly for high-purity polymer-grade and pharmaceutical intermediates.
Price points diverge sharply across grades: technical, high-purity, and custom application blocks carry substantial differences due to incremental distillation, storage, handling, and QA costs. Orders specified with additional certification layers (ISO, pharma, Kosher/Halal) or tailored impurity limits drive additional laboratory and batch processing costs. Packaging format—drums versus tank—also shifts cost structure, mainly due to packaging material, cleaning protocol, and handling risk.
The cyclical pattern of cyclopentene supply reflects base chemical demand for C5 streams. Supply is closely tied to regional refinery and cracker utilization rates. Asia’s capacity has expanded rapidly, mainly in China and India, tied to local downstream demand in cyclopentene-based adhesive, solvent, and polymer markets. Western regions (US/EU/JP) retain mature but capacity-constrained cycles, with incremental volumes dictated by downstream specialty polymer and pharmaceutical sectors.
In the US, supply flexibility is anchored to naphtha and gas feedstocks, subject to refinery blend economics. Market growth remains tied to specialty chemicals. The EU maintains stable but tightly regulated supply; REACH and safe use requirements drive procurement toward certified suppliers, often at a price premium. Japan’s market is steady, marked by recurring contract supply and limited spot activity, owing to its specialty polymer industry. India and China continue aggressive capacity expansions, with Chinese producers dominating low- to mid-grade segments but facing quality controls on high-purity grades and export restrictions. India’s sector targets backward integration, focusing on flexible sourcing and cost-positioning in the mid-purity range.
For 2026, the outlook signals moderate upward pricing pressure from energy and feedstock volatility, combined with higher regulatory compliance costs globally. Asia-based mid-grade suppliers may drive marginal cost reductions via scale but will encounter offsetting swings on logistics and compliance costs for export. Grade-specific differentials are expected to widen as demand for high-purity grades picks up, especially for use in advanced polymer and pharma synthesis.
Market commentary and price forecasts draw from internal production and sales tracking, industry data feeds, trader input, and analysis of public refinery and cracker operating data. Forward-looking commentary incorporates both contract negotiation input and empirical experience from plant operations under varying market constraints.
Recent market activity focused on compliance adaptation, capacity shifts in Asian hubs, and refinery rationalization in Western economies. Many plants prioritized campaign production for higher-purity or specialty CPE blocks to mitigate margin compression in the merchant bulk grade segment.
Key updates from US/EU agencies have raised the baseline documentation burden for market entry, particularly for regulated end-use markets. Product traceability and impurity disclosure drive batch release protocols and documentation. Asian supply chains face additional scrutiny around export declarations and quality conformance, mainly for high-purity and non-domestic orders.
In-plant process controls have become more sensitive to rapid feedback from analytical results, triggering earlier campaign stops or reruns in out-of-spec batches. Inventory management strategies now emphasize build-to-order pipelines for critical grades with high compliance attachment. Flexible packaging and dedicated QA tracks support mitigation against regulatory bottlenecks and export delays. Production teams retain dual routes for grade flexibility and risk sharing across multiple C5 fraction sources.
Cyclopentene is produced to support a diverse base of downstream sectors. In polymer and elastomer manufacturing, it serves as a monomer or comonomer. Fine chemical synthesis uses it as a reactive intermediate. In specialty fuel and oil additive production, its cyclic structure enables chemical modifications. Electronics and pharmaceutical applications demand highly controlled grades due to sensitivity to trace contaminants. Choice of grade aligns with each downstream requirement, with variants distinguished by targeted purity and impurity control during production.
| Industry | Common Applications | Recommended Grade Types |
|---|---|---|
| Polymers & Elastomers | Ring-opening polymerization, chemical modification | Industrial/Polymer Grade |
| Fine Chemicals, Synthons | Intermediate for cyclopentanol, cyclopentanone, and specialty building blocks | High-Purity Synthesis Grade |
| Fuel & Oil Additives | Octane enhancers, custom fuel chemistry | Technical/Standard Grade |
| Pharmaceutical & Electronic Uses | Precursor for APIs, specialty polymers, high-purity reagents | Ultra-High Purity Grade |
Production grade impacts the following characteristics:
Production teams evaluate the end-use, process method, and required reactivity. Rapid polymerization routes demand inhibitor controls, while pharma and fine chemical synthesis call for maximized control of residual byproducts and oligomers. Upstream route—whether steam cracking, dehydrogenation, or custom catalyst technology—affects trace impurity fingerprint.
For pharma, electronics, or food-contact streams, regulatory filings or customer audit protocols may mandate independent analysis for restricted substances and full batch traceability. QC teams support by providing process maps and impurity profiles tailored to audit scope.
Purity requirements stem from downstream chemistry. Processes, such as catalyst-driven cyclization or coupling, often depend on specific trace impurity thresholds. Differences in allowable unsaturates, aromatics, and oxygenates are handled by custom purification, informing both quota and lead-time estimates.
For large-volume customers, cost optimization shapes the balance between yield, energy input, and achievable purity. Niche customers may opt for higher individual QC investments per drum or cylinder. Each batch is allocated according to grade-uniformity protocols, reducing crossover between grades bound for distinctive regulatory climates.
Before approval, quality and technical teams coordinate sample production, packaging, and delivery according to customer-specific requirements. Shipments include batch-specific analytics and, if required, additional third-party verification to align with customer-developed test plans. Internal trial data guides support for pilot-scale validation or commercial rollout.
Production of Cyclopentene follows strict guidelines governed by internationally recognized quality management systems. Certification at the plant level, such as ISO 9001, highlights a disciplined approach to raw material sourcing, process control, and documentation standards across all operational lines. These frameworks guide training procedures, operational audits, and continuous improvement feedback. Certification serves more than a symbolic role. It forms the backbone for measurable traceability—enabling root-cause investigation, managing deviations, and upholding customer-defined release standards. For export or regulated applications, these certifications accelerate regulatory inspection clearance and reduce qualification timelines for new customer audits.
Requirements for product-specific certification grow stricter in applications tied to pharma, food-contact, and electronics. Cyclopentene placed into pharmaceutical synthesis or advanced material supply chains may demand supporting statements on residual solvents, specific impurity profiles, alignment with REACH or TSCA registration status, or compliance with regional chemical control acts. Only with internal batch data, validated analytical records, and routine audits does the production line address these requirements. Fulfilling such documentation ties directly to the plant’s validated analytical methods, covering both lot release testing and long-term stability evidence where relevant to the customer segment.
The ability to supply detailed batch records, certificates of analysis, and analytical reports depends on tightly integrated laboratory information systems. Customers request documentation packages at different frequency and granularity, often including not only standard CoA data but also line-by-line traceability for origin of raw materials, details of in-process control checks, and chain-of-custody records through packaging and logistics. In some procurement frameworks, digital document transfer, batch-level regulatory correspondence, and original testing chromatograms must accompany each batch, which places high technical requirements on plant document management.
Maintaining stable output for Cyclopentene depends on several upstream and process controls—consistent feedstock supply, real-time unit operation monitoring, and adaptive logistics. Historically, disruptions come from volatility in cyclopentadiene precursor markets or planned plant maintenance intervals. To minimize risk, the plant runs capacity planning software linked to real demand forecasts and adjusts production cycles for key customers. Flexible business cooperation may take form in volume-linked delivery scheduling, buffer stock arrangements, or framework supply agreements. These plans are best defined through joint forecasting and regular business review meetings.
Production scale of Cyclopentene is based on continuous operation of dedicated reactors and distillation systems designed around the targeted purity range. The facility’s primary bottleneck is usually linked to purification train throughput and reliability of key compression and separation subunits. Downstream customers in resins, flavors, or pharma intermediates often see supply reliability impacted by equipment turnaround schedules or local logistics interruptions. Supply capacity is managed through planned downtime minimization, scheduled redundancy in critical utilities, and a vendor-qualifying process for raw materials. These measures reduce risk and enable multi-year supply reassurance for strategic buyers.
Sample requests are evaluated for compatibility with ongoing commercial volumes and the technical suitability of the product’s available grade. Customers submit specifications and intended use cases to technical service, who match the correct Cyclopentene grade with minimal lead time. Shipments of non-commercial sample quantities involve traceable intermediate containers, controlled filling procedures, and detailed sampling certificates covering purity and critical impurity levels aligned with the product’s analytical release parameters. Turnaround time and sample batch traceability depend on current plant campaign scheduling and inventory cycle.
Business partnerships for Cyclopentene move best with alignment between end-use requirements and production capability. Contract structures may include consignment stock, volume-adjusted delivery, or joint inventory management programs. These partnership modes require periodic business process review—focusing on production scheduling flexibility, rapid shipment response for urgent cases, and technical feedback loops for special project requirements. Success in flexible cooperation links closely to real-time data sharing, open communication on forecast adjustments, and production buffer planning at both manufacturer and customer sites.
Teams in production and technical labs concentrate on advanced catalyst development for cyclopentene synthesis from both naphtha cracking and dicyclopentadiene hydrogenation. Efforts focus on selectivity improvement to minimize diene and aromatic byproducts since impurities influence downstream polymer, fragrance, and pharmaceutical uses. Polymer-grade cyclopentene draws particular interest, especially where micro-contaminant control enables specialty elastomer production. R&D groups closely track real-time process analytics, moving toward inline gas chromatography and NMR to monitor purity without requiring batch-specific off-line testing.
Market demand grows for cyclopentene in advanced elastomer formulations, particularly for high-performance automotive and specialty adhesive sectors. Proprietary grades with low residual aromatics enable better compatibility with metallocene catalysts, supporting ongoing innovation in medical-grade and food-contact elastomer systems. Epoxidation and hydroformylation R&D expand application boundaries, moving cyclopentene into fine chemical intermediates and performance additives. Application-specific grades require regular reformulation of technical guidelines, especially for electronic chemical suppliers seeking consistent dielectric behavior.
Direct control of isomeric purity and suppression of dicyclopentadiene back-formation remain central technical hurdles. Dehydrogenation residues and color body management are critical for grades destined for optical and medical downstreams. Conventional clay and silica gel purification, while effective for bulk removal, now compete with membrane and advanced distillation techniques at larger scale. New process control strategies aim for lot-to-lot reproducibility as minor deviations in trace unsaturates affect product performance for high-value markets. Recent advances center on statistical process control, rapid feedback loops, and real-time adjustment of reactor conditions, reflecting feedback from automotive and healthcare customers.
Capacity investments in Asia and North America outpace incremental demand for standard grades, but grade diversification mitigates commodity pressures. Segmented growth rates reflect the technical thresholds specific to each end use. Automotive and high-performance sealant consumption trends with regulatory and material migration restrictions. Electronic chemical segments display faster growth given stricter impurity demands that limit use of recycled feedstocks. Market participation relies increasingly on maintaining specialty and ultra-high-purity production lines, with expansion decisions guided by both regulatory shifts and customer co-development projects.
The preferred raw material route changes based on regional feedstock economics. In regions with established naphtha-cracking, direct extraction from pyrolysis gasoline remains standard, but advanced hydrogenation routes from dicyclopentadiene gain ground given integration with downstream monomer plants. High-separation distillation and in-line molecular sieving strengthen batch consistency. Modular purification trains facilitate rapid turnaround for customer-specific requirements, with process automation reducing cycle times and operator variability. Data-driven refinement of impurity-removal strategy directly links to meeting next-generation application thresholds.
In response to sustainability demands, process teams emphasize recovery and reuse of hydrogen and other utilities in both main and secondary reactions. Integration of waste heat and raw material recycling lowers overall emissions. Raw material selection prioritizes cracker-sourced over pure fossil-derived feed when analytical support demonstrates equal impurity profiles. Technical development now weighs in lifecycle metrics, moving toward biobased cyclopentene as long as color and odor standards remain consistent with petrochemical origins. Customer-driven protocols seek full disclosure of process efficiency and mass-balance sustainability for cyclopentene grades in food-packaging and pharmaceutical pipelines.
Production, QC, and technical teams provide direct guidance on grade, suitability, and impurity profiles at the request of customers’ engineers and R&D specialists. Typical requests include discussions of batch-to-batch variance, impurity-related process impact, and custom tolerances for specific downstream transformation—especially for customers developing sensitive formulations or scaling up pilot campaigns. Teams interpret analytical data relevant to each customer’s application, relying on both in-plant results and customer-supplied feedback from their own process evaluations.
After initial supply and during scale-up, staff remain available for root-cause investigations if processing inconsistencies occur. Manufacturers frequently adjust purification or blending procedures in response to end-user performance data—especially where downstream catalyst, elastomeric, or pharmaceutical manufacturing deviates from modeled specifications. Process engineers work together on joint trials, analysis correlation, and identifying interactions between cyclopentene grades and customer-specific raw materials, with results feeding back into production protocols. Solutions to issues, such as unexpected color, reactivity, or volatility shifts, typically come from a collaborative review of both customer and in-house process history.
The production team commits to root-cause analysis and non-conformance handling for every batch shipped, drawing on full documentation of manufacturing conditions, analytical backup, and in-process data archives. All claims undergo in-depth technical review with customer representatives to define the critical deviation point—be it raw material variance, transport conditions, or storage issues. Support includes responsive turnaround for corrective shipments, full traceability reporting where necessary, and open access to technical documentation for audit or regulatory needs. Enhanced logistical coordination ensures critical grades reach customer sites in conformance to handling and storage criteria outlined at order confirmation, minimizing any risk to downstream operations.
As a manufacturer specializing in Cyclopentene, we maintain direct control over every step from synthesis to shipment. Our production facilities operate using advanced catalytic dehydrogenation of cyclopentane, producing Cyclopentene at scale for chemical industry partners. By operating our own reactors, distillation columns, and quality labs, we eliminate third-party interference and deliver precise, repeatable product specifications.
We produce Cyclopentene to serve demanding downstream sectors such as specialty polymers, pharmaceutical intermediates, agrochemicals, and advanced resins. Cyclopentene’s unique five-membered ring structure enables its use in cycloaliphatic resin synthesis, specialty elastomers, and even as a key building block for lighter fuel additives. Customers draw on its reactivity profile for hydrogenation, epoxidation, and Diels-Alder applications, leveraging its purity for reliable yield in multi-step syntheses.
Dedicated technical staff oversee analytics at each batch stage. We invest in in-house gas chromatography units, moisture analyzers, and trace metal detection to confirm Cyclopentene meets contracted specifications. Batch records and retention samples back up every shipment and provide traceability. We continuously monitor feedstock purity, reaction temperatures, and pressure to reduce deviations. This discipline gives manufacturers confidence in downstream processing results, reducing costly troubleshooting.
We design our packaging methods from the ground up for industrial buyers managing scale and compliance. Cyclopentene leaves our site in seamless-steel drums, ISO tanks, or custom bulk containers, secured against leaks and optimized for plant transfer. Each container bears tamper-evident seals and full batch identifiers. Our logistics experts coordinate safe loading, temperature control, and just-in-time shipping for monthly, quarterly, or annual contract loads. This minimizes warehouse costs and assists procurement teams seeking predictable delivery.
Our technical teams support each client with startup integration, troubleshooting, and processing recommendations based on hands-on reactor experience. Whether evaluating feedstock compatibility or reviewing downstream residue performance, our lab chemists and process engineers address concerns based on real production data. Direct interaction with the manufacturing team enables faster root-cause analysis and adoption of best handling practices at the user’s site.
Procurement leaders and production managers receive quantifiable value through direct engagement with the Cyclopentene producer. Our integrated supply model removes layers of markup, improves access to documentation, and streamlines regulatory compliance checks. Consistent product, comprehensive batch records, and responsive technical input reduce operational friction and risk. Distributors working with us benefit from reliable allocation, rapid container turnover, and a transparent supply chain directly linked to the source.
Long-term partnerships with our customers arise from predictable delivery, stable pricing, and a collaborative approach to production challenges. By retaining direct control over Cyclopentene’s life cycle, we meet the requirements of manufacturers, distributors, and procurement teams seeking dependable chemical supply without market uncertainty.
Running a chemical production facility that outputs Cyclopentene means keeping clean, efficient processes at the core of every batch. Minimum purity stands as a basic benchmark, not only for performance but also for safety and compliance throughout downstream applications. Most industrial end-users expect Cyclopentene to reach at least 98% purity. Benchmarks come from practical experience working with polymerization, chemical synthesis, and specialty chemical processes, rather than theory alone.
Our equipment calibrates to maintain product within this range, and any deviation gets flagged immediately. Minor impurities, olefinic or otherwise, trigger unwanted side reactions. In catalytic applications, for instance, these contaminants can reduce catalyst life and yield, causing unplanned downtime and extra maintenance. Purity below 98% can undermine batch reliability in advanced material sectors. Reworking or flushing product lines with insufficient Cyclopentene purity would waste time, raw materials, and labor. Those costs hit both the supplier and the user.
Industrial customers look for consistency, but the reason always traces back to their own process needs. In cycloolefin copolymer production, for example, traces of aromatics or saturated hydrocarbons block critical reactions and introduce stability issues. For chemical intermediates, purity matters even more, as their role in synthesizing pharmaceuticals or crop protection agents leaves no margin for error. Today, regulatory scrutiny sharpens focus on residual solvents and unknown impurities—trace components can shut down entire product lines if not controlled tightly.
To ensure compliance, our in-house laboratory runs every lot through GC analysis and tailored impurity profiling. It is not enough to hit a number on paper. Downstream process teams rely on understanding what specific impurities—such as cyclopentane, 1,3-pentadiene, and other cyclic hydrocarbons—might slip through, and at what thresholds. Detailed reports accompany each shipment, giving full transparency from bulk tank to reactor.
Consistency at scale requires both rigorous process control and investment in purification technology. Our distillation units operate under precise temperature and vacuum settings, with active monitoring in real time. Preventive maintenance and regular system audits handle sources of cross-contamination or material carryover. We built our facility to minimize contact with extraneous hydrocarbons; this design prevents unwanted byproducts right from the start, reducing reprocessing and solid waste generation.
While customers sometimes ask about “higher” purity grades, such as 99% or above, achieving those levels often means significant scaling considerations. The decision to run at 99% depends on downstream requirements, available purification infrastructure, and cost/benefit analysis. Our standard grade at 98% handles most industrial needs while keeping production efficient and sustainable. Tailored solutions above this range are possible, but require close collaboration with technical teams to assess both feasibility and necessity. We provide detailed specifications and analytical data, paving the way for specification-driven procurement, rather than hedging with generic claims.
Every percent of purity in Cyclopentene directly affects plant safety, environmental profile, and user process efficiency. Setting the minimum at 98% avoids shortcuts, ensures batch-to-batch consistency, and cutbacks on headaches linked to process variability. Margin for error shrinks with every additional specialty use case. For us, maintaining a transparent, tightly controlled purity benchmark is not only an operational standard—it shapes product value and trust in long-term supply partnerships.
Supplying Cyclopentene (CPE) directly from our production lines has given us clear insight into the best packaging formats for reliability, efficiency, and ease of use in industrial applications. Our teams spend a lot of time refining the way we deliver this material to both large-scale chemical processors and specialty users, because consistent product integrity remains just as critical as the chemistry itself.
Cyclopentene requires careful handling and secure containment, so our storage and transport solutions focus on minimizing exposure to air, moisture, and temperature fluctuations. We have invested in various packaging systems that work for most downstream supply chains without introducing logistical hurdles.
Our MOQ reflects both production batch economics and safe logistics. We manufacture Cyclopentene to order, which requires thoughtful coordination from process start through final dispatch. For drum packaging, our minimum is a single pallet, which holds four to eight drums (about 600–1,200 kg net). IBC minimums also begin at one full container (1000 liters). For ISO tanks, we dispatch per full container because of the requirements for safe loading and transportation compliance.
Many discussions around MOQ focus on economics, but in our experience, safe movement and rapid turnaround also drive our MOQ thresholds. Full-load shipments reduce handling events and quarantine risks. They ensure product arrives fresh, directly from our process lines, and remains protected at every handling point.
In recent years, increased focus on purity profiles and batch traceability has changed how customers expect to receive Cyclopentene. Drums and IBCs, when prepared in controlled settings, maintain consistency from our reactor to the user's blending area. ISO tanks provide maximum supply chain efficiency for continuous or large volume users, supported by our internal tracking and logistics documentation every step of the way.
Our investment in these systems and packaging strategies comes from extensive dialogues with technical teams, process engineers, and supply chain managers on the receiving side. We recognize the difference between a well-sealed container and an outdated packaging approach when working with such a volatile material. Each order leaves our site with a full manifest, batch-level quality data, and clear loading documentation, tested against tight internal criteria for moisture, peroxide content, and residuals — factors critical to the performance and safety of Cyclopentene downstream.
For specialized projects or pilot quantities, our technical sales team works directly with users to match packaging size, delivery frequency, and container configuration to each site's requirements. All packaging completely aligns with current international transport safety protocols and chemical containment regulations to assure safe, reliable delivery from factory floor to end-use facility.
From our position at the source of production, regulatory documentation for Cyclopentene begins long before shipping. Our compliance approach starts within the raw materials procurement process, extends into every production batch, and continues through the chain of custody. Every shipment reflects these checks, which support strict adherence to regional chemical regulations—whether REACH for Europe, TSCA for the United States, or frameworks active in Asia and beyond.
For exports to the European Union, REACH registration remains non-negotiable. We hold a valid REACH registration for our Cyclopentene, confirming that only pre-registered or fully registered volumes leave our plant. The dossier contains substance identity, production volumes, uses, robust study summaries, test reports on chemical and toxicological properties, and exposure scenarios for all declared uses. Our safety and regulatory teams coordinate with Only Representative partners or local offices to update these dossiers regularly.
Our documentation package always includes up-to-date Material Safety Data Sheets. These follow the GHS format where required, and they reflect the correct language, regulatory references, and hazard classifications according to the destination country. We refresh them as soon as regulatory changes occur or when our internal studies yield new hazard data. Detailed exposure control and personal protective equipment requirements come from direct experience working with the material and evolving best practices in handling volatile olefins.
Each batch of Cyclopentene comes with a Certificate of Analysis documenting actual test results: purity, moisture content, key impurity levels, and other critical QC metrics. We do not simply state that “it meets specification”—the results are batch-specific, reflecting real-world conditions in our facilities. Our systems keep full batch traceability using unique lot numbers, linking every drum or tank container to the raw data. This assures customers and authorities that our process control matches our regulatory documentation.
Some customers require declarations for other jurisdictional controls—TSCA Inventory for the US, IECSC for China, or K-REACH for Korea. We keep these records in a digital compliance archive. We supply origin declarations, absence statements for Annex XVII restrictions, and, when requested, documentation verifying non-use of SVHC-listed substances in production. These are not generic; our regulatory staff review and sign off on every version.
We operate under ISO 9001 and RC14001 certified quality and environmental management systems, regularly audited by partners and authorities. Our internal compliance protocols update as regulations shift. We open our compliance files for review by environmental and customs inspectors whenever requested, as transparency is embedded in the way we manufacture and distribute Cyclopentene.
New restrictions and evolving scientific findings constantly influence compliance. Our technical department reviews every update to annexes or guidance documents. When regulations change, we adjust production, analytical methods, or labeling. We assist downstream users with supply chain communication, quickly sharing any new data on risk mitigation. Years of close interaction with regulatory bodies help us streamline this process, reducing disruptions and expediting market access for our customers.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
